Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

March 01, 1986; Volume 29,Issue 3
  • You have access
    Synthesis and characterization of a high affinity radioiodinated probe for the alpha 2-adrenergic receptor.
    S M Lanier, H J Hess, A Grodski, R M Graham and C J Homcy
    Molecular Pharmacology March 1986, 29 (3) 219-227;
  • You have access
    Effects of temperature and membrane phase transitions on ligand binding to alpha 2-receptors of human platelets.
    M J Lohse, K N Klotz and U Schwabe
    Molecular Pharmacology March 1986, 29 (3) 228-234;
  • You have access
    Solubilization of [3H]leukotriene D4 receptor complex from guinea pig lung membranes.
    S Mong, H L Wu, J M Stadel, M A Clark and S T Crooke
    Molecular Pharmacology March 1986, 29 (3) 235-243;
  • You have access
    Uncoupling of gamma-aminobutyric acid B receptors from GTP-binding proteins by N-ethylmaleimide: effect of N-ethylmaleimide on purified GTP-binding proteins.
    T Asano and N Ogasawara
    Molecular Pharmacology March 1986, 29 (3) 244-249;
  • You have access
    Molecular mechanisms of the potent and stereospecific nicotinic receptor agonist (+)-anatoxin-a.
    K L Swanson, C N Allen, R S Aronstam, H Rapoport and E X Albuquerque
    Molecular Pharmacology March 1986, 29 (3) 250-257;
  • You have access
    Inhibition of Ns-stimulated human platelet adenylate cyclase by forskolin.
    Y Watanabe and K H Jakobs
    Molecular Pharmacology March 1986, 29 (3) 258-263;
  • You have access
    Modulation of calmodulin function and of Ca2+-induced smooth muscle contraction by the calmodulin antagonist, HT-74.
    T Tanaka, H Umekawa, M Saitoh, T Ishikawa, T Shin, M Ito, H Itoh, Y Kawamatsu, H Sugihara and H Hidaka
    Molecular Pharmacology March 1986, 29 (3) 264-269;
  • You have access
    The effect of 16 beta-substitution on the structure and activity of digitoxigenin: is there an additional binding interaction with Na+,K+-ATPase?
    J F Griffin, D C Rohrer, K Ahmed, A H From, T Hashimoto, H Rathore and D S Fullerton
    Molecular Pharmacology March 1986, 29 (3) 270-274;
  • You have access
    Uptake of meta-iodobenzylguanidine by bovine chromaffin granule membranes.
    B Gasnier, M P Roisin, D Scherman, S Coornaert, G Desplanches and J P Henry
    Molecular Pharmacology March 1986, 29 (3) 275-280;
  • You have access
    Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies.
    B Giros, C Gros, B Solhonne and J C Schwartz
    Molecular Pharmacology March 1986, 29 (3) 281-287;
  • You have access
    Effects of mercury (II) compounds on the activity of dUTPases from various sources.
    M V Williams
    Molecular Pharmacology March 1986, 29 (3) 288-292;
  • You have access
    Effect of the polar head structure of polyene macrolide antifungal antibiotics on the mode of permeabilization of ergosterol- and cholesterol-containing lipidic vesicles studied by 31P-NMR.
    B Cybulska, M Herve, E Borowski and C M Gary-Bobo
    Molecular Pharmacology March 1986, 29 (3) 293-298;
  • You have access
    Regional difference in brain benzodiazepine receptor carbohydrates.
    P M Sweetnam and J F Tallman
    Molecular Pharmacology March 1986, 29 (3) 299-306;
  • You have access
    Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs.
    A C Howlett, J M Qualy and L L Khachatrian
    Molecular Pharmacology March 1986, 29 (3) 307-313;
  • You have access
    Proposals for the mu-active conformation of the enkephalin analog Tyr-cyclol(-N gamma-D-A2-bu-Gly-Phe-Leu-).
    B Maigret, M C Fournie-Zaluski, B Roques and S Premilat
    Molecular Pharmacology March 1986, 29 (3) 314-320;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 29, Issue 3
1 Mar 1986
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics